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ABSTRACT
In vivo mutagenicity and carcinogenicity studies are posing a high demand for test-
related resources. Among these studies, the micronucleus test in rodents is the most 
widely used, as follow up to positive in vitro mutagenicity results. A recent survey of 
the (Q)SAR models for mutagenicity and carcinogenicity has indicated that no 
(Q)SAR models for in vivo micronucleus are available in the public domain. 
Therefore, the development and extensive use of estimation techniques such as 
(Q)SARs, read-across and grouping of chemicals, promises to have a huge animal 
saving potential for this endpoint. In this report, we describe the identification of 
structural alerts for the in vivo micronucleus assay, and provide the list of underlying 
chemical structures. These structural alerts provide a coarse-grain filter for the
preliminary screening of potential in vivo mutagens.  
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61. Introduction
Mutagenicity testing is an important part of the regulatory hazard assessment of 
chemicals. It is undertaken for two main reasons: a) to detect chemicals that might 
cause genetic damage in germ cells, and thus increase the burden of heritable 
(genetic) disease in the human population; and b) to detect chemicals that might be 
carcinogenic (based on the assumption that mutagenesis, for example in somatic cells, 
is a key event in the process of carcinogenesis). Since no method is able alone to 
detect all possible genotoxic events, a wide array of test systems has been developed 
and accepted internationally in regulatory schemes. 
Most often, these methods are used within a 2-tiered integrated testing approach: Tier 
1 includes in vivo assays, and Tier 2 includes in vivo assays. As a matter of fact, 
mutagenicity testing was the first toxicity endpoint for which in vivo assays were 
accepted for regulatory testing, some 25 years ago. The latter usually comprise 
bacterial mutagenicity and cytogenetics tests, although gene mutation testing in 
cultured mammalian cells is sometimes also undertaken. 
Tier 2 of the testing strategy involves the use of short-term in vivo studies (usually a 
bone-marrow cytogenetics assay) to assess whether any potential for genotoxicity
detected at the Tier 1 in vivo stage is actually expressed in the whole animal. Thus, 
negative results in vivo are usually considered sufficient to indicate lack of 
mutagenicity, whereas a positive result is not considered sufficient to indicate that the 
chemical represents a mutagenic hazard (i.e. it could be a false positive). The above 
approach to genotoxicity testing has been adopted throughout the EU1, and has been 
recommended internationally as part of the strategy for predicting and quantifying 
mutagenic and carcinogenic hazard (Ashby et al., 1996; Combes et al., 2007; Kirkland 
and Speit, 2008; Lilienblum et al., 2008).
 
  
1
http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_r7a_en.p
df?vers=20_08_08
7According to an assessment carried out by the former European Chemicals Bureau 
(ECB), the in vivo mutagenicity studies, shortly followed by carcinogenicity, are 
posing high demand for test-related recourses (Pedersen et al., 2003; Van der Jagt et 
al., 2004). Among those, the micronucleus test in rodents is the most widely used, as 
follow up to positive in vivo mutagenicity results. A recent survey of the (Q)SAR 
models for mutagenicity and carcinogenicity (performed jointly by ISS and the JRC) 
has indicated that no (Q)SAR models for in vivo micronucleus are available in the 
public domain (Benigni et al., 2007): therefore, the development and extensive use of 
estimation techniques such as (Q)SARs, read-across and grouping of chemicals, might 
have a huge saving potential for this endpoint. 
In this report, we describe: a) the collection of data on chemicals tested with the in 
vivo micronucleus assay;  b) preliminary analyses of the data; c) the identification of 
Structural Alerts (SA) proper to this toxicological endpoint. First, some background 
information on the concept of SA is provided.
82. Structural alerts
The SAs for a toxicological endpoint are molecular functional groups or 
substructures known to be linked to that type of toxicity. The SAs are a coarse-grained 
approach to the use of  Structure-Activity Relationships (SAR) to understand the 
toxicity mechanisms and to predict the toxic activity of chemicals. Because of their 
nature, the SAs have the role of pointing to chemicals potentially toxic, whereas no 
conclusions or indications about nontoxic chemicals are possible (except by 
exclusion) (Benigni and Bossa, 2006; Benigni and Bossa, 2008). 
A set of chemicals characterized by the same SA constitute a family (class) of 
compounds that share the same mechanism of action. The reactivity of a SA can be 
modulated or abolished by the remaining part of the molecule in which the SA is 
embedded. At a coarse-grain level, such modulating effects can be represented by 
other molecular substructures (e.g., bulky groups ortho to an aromatic amine group) 
that are known to have an influence on the reactivity of the SA. Usually, the 
knowledge on the modulating substructures is quite limited for most of the SAs, thus 
it provides limited help in deciding which chemicals in a class will actually be toxic 
and viceversa. A powerful generalization of the Structure-Activity Relationships is 
provided by the Quantitative Structure-Activity Relationship (QSAR) analysis, which 
produces a mathematical model that links the biological activity to a limited number 
of physical chemical or other molecular properties (descriptors) with general 
relevance. Since most of the descriptors have continuous values, the QSARs provide 
fine-tuned models of the biological activity, and can give account of subtle 
differences. General introductions on QSAR are given elsewhere (Hansch and Leo,
1995, Hansch et al., 2002). Thus the SAs are not a discriminant model on the same 
ground of the QSAR models: the latter produce estimates for both positive and 
negative chemicals, as well as for the gradation of toxic potency. 
The main role of the SAs is that of preliminary, or large-scale screenings. They are 
excellent tools for coarse-grain characterization of chemicals, including: description 
of sets of chemicals, preliminary hazard characterization, category formation and 
priority setting (enrichment). Since fine-tuned QSARs do not exist for many types of 
chemicals, the models based on SAs hold a special place in predictive toxicology. The 
9knowledge on the action mechanisms as exemplified by the SAs is routinely used in 
SAR assessment in the regulatory context (see, for example, the mechanistically-
based reasoning as presented in Woo et al. (2002). In addition, the SAs are at the basis 
of popular commercial (e.g., DEREK, by Lhasa Ltd.2) and non-commercial software 
systems (e.g., Oncologic, by US Environmental Protection Agency [EPA]3).
Recently, as follow-up of the collaboration between ISS and JRC, a rulebase for 
mutagens and carcinogens has been designed and implemented in the software 
Toxtree 1.51. It uses a structure-based approach consisting of a new compilation of 
SAs for carcinogenicity and mutagenicity. It also offers three mechanistically based 
QSARs for congeneric classes (aromatic amines and aldehydes) (Benigni et al., 
2008a).  Toxtree 1.51 is freely available from the JRC website.4
  
2 http://www.lhasalimited.org/
3 http://www.epa.gov/oppt/newchems/tools/oncologic.htm
4 http://ecb.jrc.ec.europa.eu/qsar/qsar-tools/index.php?c=TOXTREE
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3. Development of structural alerts for the in vivo
micronucleus assay
3.1 Data
The compilation of SAs for the in vivo micronucleus assay in rodents provided here, 
is based on both the existing knowledge on the mechanisms of toxic action and a 
structural analysis of the chemicals tested in the assay.
The in vivo micronucleus data in the public domain is quite limited. A search of the 
Chemical Carcinogenesis Research Information System (CCRIS) at the Toxnet 
website with the query: “in vivo micronucleus” points only to 240 chemicals.5
For this work, the remarkably larger commercial database by Leadscope Inc., called 
“FDA SAR Genetox Database” was used.6 This database contains more than 700 
chemicals tested in in vivo micronucleus with rodents, and includes data from both the 
public domain and the US Food and Drug Administration (FDA) files. A large 
majority of data were based on the analysis of micronuclei in bone marrow cells; for 
details on the technique, see for example, Krishna and Hayashi (2000).
3.1 Preliminary analyses
Since the main role of the in vivo micronucleus assay in regulatory schemes is that of 
confirming (or disproving) the positive in vitro results, it is of interest to check how 
the in vivo micronucleus results relate to the rodent carcinogenicity data and to the 
primary in vitro prediction test, i.e., the Salmonella typhimurium (Ames) test. 
Tables I and II display the relationships between the in vivo micronucleus ad the two 
reference tests. The results for rodent carcinogenicity and the Ames test were 
retrieved from the freely available ISSCAN v3a database,7 which is characterized by: 
  
5 http://toxnet.nlm.nih.gov/cgi-bin/sis/search
6 http://www.leadscope.com/product_info.php?products_id=77
7 http://www.iss.it/ampp/dati/cont.php?id=233&lang=1&tipo=7
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a) the high quality of both chemical and biological information; b) the QSAR-ready 
format (Benigni et al., 2008b). Obviously, the total numbers of chemicals in the two 
tables are relative only to those chemicals tested in both systems.
Table I. Contingency table comparing the results of the rodent carcinogenicity test 
with the micronucleus test
Carcinogenicity test Micronucleus test
Negative Positive Total
Negative 30 10 40
Positive 86 57 143
Total 116 67 183
 
Table II: Contingency table comparing the results of the Salmonella typhimurium
assay with the micronucleus test
Salmonella assay Micronucleus test
Negative Positive Total
Negative 74 36 110
Positive 41 34 75
Total 115 70 185
Table I shows that is the in vivo micronucleus assay is poorly sensitive to the rodent 
carcinogens: about 60% of the rodent carcinogens are not detected by the 
micronucleus. The poor sensitivity of the micronucleus assay to potential genotoxins 
is also apparent from Table II. 
It should be emphasized that the present results obtained with the large Leadscope 
micronucleus database are in agreement with previous analyses based on smaller 
datasets in the public domain (Benigni, 1995).
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In a second round of analyses, the extent to which the micronucleus data are related to 
well established indicators of DNA and protein binding was checked. This in view of 
the plethora of the reported mechanisms of micronucleus induction. As a matter of 
fact, micronuclei are markers of both aneugenic (change in the chromosomes number, 
usually by loss) and clastogenic (chromosome breakage) effects. It is generally 
assumed that such effects are generated through a range of different pathways. 
Evidence (mainly gathered from in vitro studies) indicates that micronuclei can be 
induced e.g., by typical DNA-attacking agents (e.g., alkylating agents like 
methylmethane sulfonate), by mitotic spindle poisons (e.g., colcemide, vincristine), or 
by inhibitors of cytokinesis (e.g., cytochalasin B). The latter effects are probably due 
to interference with proteins. Other chemicals are thought to be clastogenic through 
aspecific disturbance of cytokinesis due to lipophilicity (Dorn et al., 2007).
The relative influence of DNA and protein binding on micronucleus generation was 
checked by recording the distribution of structural alerts for the two effects in the 
Leadscope in vivo micronucleus database. As probes for DNA binding, we used the 
structural alerts for carcinogenicity / mutagenicity implemented in Toxtree 1.51. As a 
matter of fact, the large majority of these alerts refer to genotoxic carcinogenicity, 
which is assumed to be caused through direct interaction with DNA (Benigni and 
Bossa, 2008). As probes for protein binding, we used the alerts implemented in the 
Organisation for Economic  Cooperation and Development (OECD) QSAR Toolbox.8
These alerts were mainly developed from the mechanistic knowledge on skin 
sensitization, and model the covalent binding to proteins.
The results of the above analysis is displayed in Figure 1 as a ROC graph. It appears 
that the structural alerts for carcinogenicity / mutagenicity correlate to some extent 
with the induction of micronuclei, whereas those for protein covalent binding show no 
correlation (in the graph, they are on the diagonal line which represents random 
results).
  
8 http://www.oecd.org/document/23/0,3343,en_2649_34379_33957015_1_1_1_1,00.html
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 Figure 1. Receiver Operating Curve showing the concordance of two sets of 
structural alerts with the results of the in vivo micronucleus assay
(SA_BB refers to the Benigni-Bossa alerts in Toxtree; SA_Prot refers to the alerts for protein 
binding in the OECD QSAR Toolbox)
3.3 Structural Alerts for in vivo micronucleus assay
Since the above analyses pointed to genotoxic effects as an important determinant of 
micronuclei induction, we developed the list of Structural alerts for in vivo
micronucleus using the carcinogenicity / mutagenicity alerts in Toxtree as a core , and 
then searching for additional substructures specific to the micronucleus-positive 
chemicals. From the Toxtree alerts for carcinogenicity / mutagenicity, we excluded 
four alerts specific for non-genotoxic mechanisms of carcinogenicity. 
Using linear discriminant analysis as an analytical tool and ROC plots as a graphical 
tool, a series of additional substructures were added / removed to / from the Toxtree 
alerts in order to increase sensitivity and specificity. In these exploratory analyses, we 
14
screened the very large collection of substructural patterns and functional groups 
(more than 27,000) contained in the software Leadscope Enteprise 2.4.15-6. We also 
re-checked the Toolbox protein binding alerts for individual substructures related with 
micronucleus induction.  
The result is the optimized list of alerts in Appendix 1. Together with the Toxtree 
alerts, it contains five additional substructures identified in the course of this research. 
For the sake of clarity, the codes of the alerts in Toxtree are maintained, whereas the 
five additional alerts have new codes.
Figure 2 displays the agreement between the alerts for in vivo micronucleus, and the 
experimental results for this endpoint. Out of 547 negatives, the specificity of the SAs 
is 0.57. The sensitivity is 0.65 out of 182 positives.  The overall accuracy is 0.59. For 
a comparison, the ROC graph shows the newly developed alerts for micronucleus 
together with those for DNA and protein binding. It appears that the performance of 
the final list of alerts is considerably higher than that of the DNA binding and Protein 
binding alerts.
Table III gives the true positive rate for the individual alerts.
15
Figure 2  Receiver Operating Curve showing the concordance of structural alerts for 
the in vivo micronucleus assay with the experiemtnal results for this assay
(SA_Mic refers to the in vivo micronucleus alerts in Toxtree)
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Table III: Characterisation of Structural Alerts.
STRUCTURAL ALERT No. Substances fired
No. of 
positive 
substances
True 
Positives 
(%)
SA_1: acyl halides 0 0
SA_2: alkyl (C<5) or benzyl ester of sulphonic 
or phosphonic acid 4 3 75
SA_3: N-methylol derivatives 1 0 0
SA_4: monohaloalkene 3 3 100
SA_5: S or N mustard 4 4 100
SA_6 : propiolactones or propiosultones 0 0
SA_7: epoxides and aziridines 20 12 60
SA_8: aliphatic halogens 35 9 26
SA_9: alkyl nitrite 1 1 100
SA_10:  a, b unsaturated carbonyls 58 16 28
SA_11: simple aldehyde 9 2 22
SA_12: quinones 9 4 44
SA_13: hydrazine 6 0 0
SA_14: aliphatic azo and azoxy 0 0
SA_15: isocyanate and isothiocyanate groups 2 0 0
SA_16: alkyl carbamate and thiocarbamate 9 2 22
SA_18: Polycyclic Aromatic Hydrocarbons 1 1 100
SA_19: heterocyclic Polycyclic Aromatic 
Hydrocarbons 7 0 0
SA_21: alkyl and aryl N-nitroso groups 6 5 83
SA_22: azide and triazene groups 2 2 100
SA_23: aliphatic N-nitro group 2 1 50
17
SA_24:  a, b unsaturated aliphatic alkoxy group 1 1 100
SA_25: aromatic nitroso group 0 0
SA_26: aromatic ring N-oxide 0 0
SA_27: nitro-aromatic 17 2 12
SA_28: primary aromatic amine, hydroxyl 
amine and its derived esters 50 19 38
SA_28bis: aromatic mono- and dialkylamine 5 2 40
SA_28tris: aromatic N-acyl amine 2 0 0
SA_29: aromatic diazo 8 4 50
SA_30: coumarins and Furocoumarins 3 0 0
SA_32: 1,3-dialkoxy-benzene 6 5 83
SA_33: 1-phenoxy-benzene 5 4 80
SA_34: hacceptor-path3-hacceptor 163 55 34
SA_35: cxolane 21 9 43
SA_36: carbodiimides 2 2 100
3.4 Further analyses on the alerts for micronucleus
A striking evidence in Table III is the relatively low percentage of true positives 
identified by many SAs. In other words, often the toxic potential of the alerts is not 
translated into actual toxicity in the experimental system. For a comparison, the True 
Positive Rate of the various alerts for mutagenicity  / carcinogenicity in Toxtree is 
remarkably higher, ranging from 70 to 100% (Benigni and Bossa, 2008). 
The above result contributes to better understand the evidence in Tables I and II, 
where it appears that the micronucleus assay has many more negatives than the 
carcinogenicity bioassay and the Salmonella mutagenicity test. Table III indicates that 
the low sensitivity of the micronucleus assay is largely due to the fact that often, 
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chemical functionalities and substructures which are supposed to be reactive do not 
exert their potential reactivity in this experimental system.
The issue of the low sensitivity of the micronucleus assay has been recognized by 
scientists involved in research aimed at improving the available short-term 
mutagenicity assays; as a matter of fact, validation of further, more sensitive in vivo
assays (e.g., in vivo Comet assay) is presently in progress (Kirkland and Speit, 2008). 
In the context of this research, we investigated if a general effect of bioavailability on 
the limited sensitivity of micronucleus was apparent. To this aim, we considered two 
chemical descriptors well known as to be linked to bioavailability: logP 
(hydrophobicity) and Molar Refractivity (MR) (Hansch and Leo, 1995). The two 
descriptors were calculated with the C-QSAR software (Daylight, Inc.)9 for all the 
chemicals in the micronucleus database. For the two parameters, Table IV reports the 
ranges of values for positive and negative micronucleus results.  
 
Table IV: Ranges of C-logP and C-MR in chemicals assayed with 
the micronucleus test
C-logP C-MR (x 10-1)
Micronucleus Negatives -18.64 – 20.43 0.10 –  33.73
Micronucleus Positives -9.58  – 15.23 0.15  –  32.91
 
It appears that the micronucleus positives cover a more limited range of logP values 
than the micronucleus negatives; however, the consideration of exclusion values for 
logP in combination with the SAs did not improve the overall performance (results 
not shown).
Whereas no general effect of logP (or MR) was found, analyses on the individual 
chemical classes showed that logP cut-offs can be identified for the classes of  
Nitroaromatics (Negatives at logP > 0.0), Aromatic Diazo (Negatives at logP < 3.7), 
  
9 http://www.daylight.com/about/index.html
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and Oxolanes (Negatives at logP > 1.5). The consideration of these cut-offs increases 
the specificity of the SAs from 0.57 to 0.60. 
The above result suggests a possible strategy to understand and modeling the many 
negative results observed with the micronucleus. Since the bone marrow (main target 
of the test) is an organ easily accessible by the blood stream, it can be hypothesized 
that the lack of effect shown by several chemicals with SAs (hence potentially 
reactive) is due to the many possible targets for reaction encountered in the in vivo
situation; this diminishes the probability for the chemicals of reaching, and interacting 
with the molecular target(s) of the micronucleus test. For example, highly reactive 
chemicals will probably react with any target encountered in their way (e.g., proteins, 
water) before reaching the bone marrow.  Thus it can be envisaged that QSARs for 
individual chemical classes should be developed, and that they should consider 
parameters linked to chemical reactivity (such as HOMO and LUMO energies). It can 
be hypothesized that the models derived from these QSARs will contribute to 
modulate the individual SAs.
20
4. Final considerations
Structural alerts point to classes of chemicals with the potential to cause toxic effects 
(here, in vivo micronucleus). Since this potential is modulated in each molecule by the 
rest of the structure (e.g., other functional groups, electronic structure, bulky groups), 
not all chemicals in a class are equally toxic. In the case of the SAs identified in the 
present study for the in vivo micronucleus test, the percentage of chemicals that have 
SAs but are not active in the test system is particularly high. This evidence agrees 
with, and rationalizes the notion that this test system is sensitive to genotoxins to a 
limited extent, and does not respond to a large number of recognized carcinogens and 
mutagens. For this reason, a positive in vivo micronucleus result adds a strong weight 
to an in vivo positive mutagenicity result, whereas a negative in vivo micronucleus 
result has a much lower relevance. The availability of a wider range of in vivo
mutagenicity assays is a priority for the present regulatory strategies. 
Within the above perspective, the SAs identified in this study provide a coarse-grain 
filter for a preliminary screening of potentially in vivo mutagens. In a risk assessment 
process, further information (e.g., QSARs for individual classes, experiments) is 
necessary to complete this initial screening step.
21
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Appendix 1
STRUCTURAL ALERT DETAILS AND EXAMPLES
SA_1:  Acyl halides
O
[Br,Cl,F,I]R
R = any atom/group, except OH, SH
No representatives
SA_2: alkyl (C<5) or benzyl ester of 
sulphonic or phosphonic acid
P
O
R1
O O
R R
S
O
O
OR1
R R= Alkyl with C<5 (potentially substituted by 
halogens), or benzyl
R1= any atom/group except OH, SH, O-, S-
O
S
CH3
O
O
CH3
Name: Ethyl Methanesulfonate
CAS: 62-50-0
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SO CH3
O
OCH3
Name: Methyl Methanesulfonate
CAS: 66-27-3
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
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SA_3: N-methylol derivatives
NR
R
CH2
OH
R = any atom/group
No positive representative
SA_4: Monohaloalkene
[Br,Cl,F,I]
R1
R2
R3
R1, R2 (or R3) = H or Alkyl
R3 (or R2) = any atom/group except halogens
Cl
Cl
Name: 1,3-dichloropropene
CAS: 542-75-6
In vivo Micronucleus (Rodent): Positive
Reference: NTP
CH3
CH3 Cl
Name: Dimethylvinyl Chloride
CAS: 513-37-1
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_5: S or N mustard 
[Br,Cl,F,I]
N
[Br,Cl,F,I]
R
or
[Br,Cl,F,I]
S
[Br,Cl,F,I]
R = any atom/group
25
O
OH
N
Cl
Cl
Name: Chloroambucil
CAS: 305-03-3
In vivo Micronucleus (Rodent): Positive
Reference: NTP
NH2
N
Cl
Cl
O
OH
Name: Melphalan
CAS: 148-82-3
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_6 Propiolactones or propiosultones
O
O
or 
S
O
O
O
Any substance with the displayed substructures
No representatives
SA_7:Epoxides and aziridines
O
or 
N
R
R = any atom/group
O
26
Name: Ethylene Oxide
CAS: 75-21-8
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
N N
NN N
N
Name: Triethylenemelamine
CAS: 51-18-3
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_8: Aliphatic halogens
[Br,Cl,I]
H
R
R
R = any atom/group
Br
Br
Name: 1,2-dibromoethane
CAS: 106-93-4
In vivo Micronucleus (Rodent): Positive
Reference: NTP
CH3
Cl
Cl
Name: 1,1-dichloroethane
CAS: 75-34-3
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
SA_9: Alkyl nitrite R= any alkyl group
27
N
O
O
R
O
N
O
CH3
CH3
Name: Isobutyl Nitrite
CAS: 542-56-3
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_10: a, b unsaturated carbonyls
O
R
R1
R2
R1 and R2 = any atom/group, except alkyl chains 
with C>5 or aromatic rings.
R= any atom/group, except OH, O-
O
O
OH
CH3
Name: Maltol
CAS: 118-71-8
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
CH2
O
NH2
Name: Acrylamide
CAS: 79-06-1
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
SA_11: Simple aldehyde R= aliphatic or aromatic carbon
a,b unsaturated aldehydes are excluded
28
O
H R
CH3
O
O
Name: Pyruvaldehyde
CAS: 78-98-8
In vivo Micronucleus (Rodent): Positive
Reference: Leadscope
SO
CH3
Name: 3-(methylthio)propionaldehyde
CAS: 3268-49-3
In vivo Micronucleus (Rodent): Positive
Reference: Leadscope
SA_12: Quinones
O
O or 
O
O
Any substance with the displayed substructures
O
O
Name: 9,10-Anthraquinone
CAS: 84-65-1
In vivo Micronucleus (Rodent): Positive
Reference: NTP
29
N NH
O
O
O
ONH2
O
NH2
CH3
CH3
H
H
H
Name: Mitomycin C
CAS: 50-07-7
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS & NTP
SA_13: Hydrazine
N N
R
R R
R
R= any atom/group
No positive representative
SA_14: Aliphatic azo and azoxy
N N
R1 R1 or 
N
+
N
-
R2
R2
or 
N
N
+
O
-
R3
R4
R1= Aliphatic carbon or hydrogen
R2, R3 = Any atom/group
R4 = Aliphatic carbon
No representatives
SA_15: isocyanate and isothiocyanate groups
N
C
O
R
or N
C
S
R R= any atom/group
No positive representative
SA_16: alkyl carbamate   and  
thiocarbamate
R = Aliphatic carbon or hydrogen
R1 = Aliphatic carbon
30
N
[O,S]
[O,S]
R1
R
R
NH2
O
O CH3
Name: Urethane
CAS: 51-79-6
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS & NTP
SA_18: Polycyclic Aromatic Hydrocarbons Three or more fused rings, not heteroaromatic
CH3
CH3
Name: 7,12-Dimethylbenz(a)anthracene
CAS: 57-97-6
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS & NTP
SA_19: Heterocyclic Polycyclic Aromatic 
Hydrocarbons Three or more fused rings, heteroaromatic
No positive representative
SA_21: alkyl and aryl N-nitroso groups
N
N
O
R2
R1
R1= Aliphatic or aromatic carbon, 
R2= Any atom/group
N N
CH3
NH2
O
O
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Name: N-methyl-N-nitrosourea
CAS: 684-93-5
In vivo Micronucleus (Rodent): Positive
Reference: NTP
N
NCH3
CH3
O
Name: N-nitrosodimethylamine
CAS: 62-75-9
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
SA_22: azide and triazene groups
N
N
N
R
R
R or N
N
+
N
-
R
R= Any atom/group
N
N
NH
Name: Diazoaminobenzene
CAS: 136-35-6
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS & NTP
N
NH
O
O
CH3
O
N
+N
-
N
OH
Name: Zidovudine
CAS: 30516_87-1
32
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_23: aliphatic N-nitro group
N
N
+
O
-
O
R
R
R= Aliphatic carbon or hydrogen
CH3
N
N
NH
NH
O
N
+
O
-
O
Name: N-methyl-N'-nitro-N-
nitrosoguanidine
CAS: 70-25-7
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
SA_24: a, b unsaturated aliphatic alkoxy 
group
O
R2
H
R1
H
R1= Any aliphatic Carbon
R2 = Aliphatic or aromatic carbon
CH3 O CH2
O
Name: Vinyl Acetate
CAS: 108-05-4
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_25: aromatic nitroso group
Ar
N
O
Ar = Any aromatic/heteroaromatic ring
No positive representative
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SA_26: aromatic ring N-oxide
N
+
O
-
Any aromatic or heteroaromatic ring
No positive representative
SA_27: Nitro-aromatic
Ar N
+
O
-
O
Ar = Any aromatic/heteroaromatic ring 
· Chemicals with ortho-disubstitution, or 
with an ortho carboxylic acid substituent 
are excluded. 
· Chemicals with a sulfonic acid group (-
SO3H)   on the same ring of the nitro 
group are excluded. 
N
N
OH
CH3N
+
O
-
O
Name: Metronidazole
CAS: 443-48-1
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
S
NN
N
NO
N
+
O
-
CH3
NH2
Name: CL 64855
CAS: 19622-55-0
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
SA_28: primary aromatic amine, hydroxyl 
amine and its derived esters
Ar = Any aromatic/heteroaromatic ring 
R= Any atom/group
· Chemicals with ortho-disubstitution, or 
34
N
HH
Ar or 
N
Ar
O
H
R
or Ar
NR
O
O
H
or amine generating group:
Ar
N
CH2
or Ar
N
O
with an ortho carboxylic acid substituent 
are excluded. 
· Chemicals with a sulfonic acid group (-
SO3H)   on the same ring of the amino 
group are excluded. 
NH2
Name: Aniline
CAS: 62-53-3
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS & NTP
NH2
Name: 4-Biphenylamine
CAS: 92-67-1
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_28bis: Aromatic mono- and 
dialkylamine
N
R2R1
Ar
Ar = Any aromatic/heteroaromatic ring 
R1 = Hydrogen, methyl, ethyl
R2 = Methyl, ethyl
· Chemicals with ortho-disubstitution, or 
with an ortho carboxylic acid substituent 
are excluded. 
· Chemicals with a sulfonic acid group (-
SO3H)   on the same ring of the nitro 
group are excluded.
35
N
CH3
CH3
N
CH3
CH3
Name: Leucomalachite Green
CAS: 129-73-7
In vivo Micronucleus (Rodent): Positive
Reference: NTP
N N N
CH3
CH3
Name: 4-Dimethylaminoazobenzene
CAS: 60-11-7
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
SA_28tris: aromatic N-acyl amine
N
Ar
R
O
R
Ar = Any aromatic/heteroaromatic ring 
R = Hydrogen, methyl
· Chemicals with ortho-disubstitution, or 
with an ortho carboxylic acid substituent 
are excluded.  
· Chemicals with a sulfonic acid group (-
SO3H)   on the same ring of the nitro 
group are excluded. 
No positive representative
SA_29: Aromatic diazo
N N
Ar Ar
Ar = Any aromatic/heteroaromatic ring 
· Chemicals with a sulfonic acid group (-
SO3H) on both rings that contain linked to 
the diazo group are excluded.
Cl
Cl
N
N Cl
Cl
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Name: 3,3’,4,4’-Tetrachloroazobenzene 
CAS: 14047-09-7
In vivo Micronucleus (Rodent): Positive
Reference: NTP
N
N N
CH3
CH3
Name: 4-Dimethylaminoazobenzene
CAS: 60-11-7
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
SA_30: Coumarins and Furocoumarins
O O
Any substance with the displayed substructure
No positive representative
SA_32:  1,3-dialkoxy-benzene
O
R
O
R
R= any alkyl group
37
O
H
O
CH3
O
CH3
NH
CH3
O
OCH3 O
CH3
Name: Colchicine
CAS: 64-86-8
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
N
H H
N
H
H
O
O
O
O
O
OO
O
O
C
CH3
CH3
C
CH3
CH3
Name: Reserpine
CAS: 50-55-5
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_33: 1-phenoxy-benzene Any substance with the displayed substructure.
38
O
O
O
CH3
CH3
F
F
F
Cl
O
N
Name: Lambda-cyhalothryn
CAS: 91465-08-6
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS
SA_34: hacceptor-path3-hacceptor
H-bond-Acc
A
A
H-bond-Acc
A= Any atom, except Hydrogen
H-bond-Acc= Any atom that is a potential 
Hydrogen bond acceptor
OO
Name: p-Dioxane
CAS: 123-91-1
In vivo Micronucleus (Rodent): Positive
Reference: CCRIS & NTP
39
O
OH OH
OH
Name: 3,4-Dihydroxycinnamic acid
CAS: 331-39-5
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_35: Oxolane
O
Any substance with the displayed substructure.
N
O
OH
N
O
N
OH
OH
NH2
Name: 5-Azacytidine
CAS: 320-67-2
In vivo Micronucleus (Rodent): Positive
Reference: NTP
OH
O
N
OH
N
N
OH NH2
O
Name: Ribavirin
CAS: 36791-04-5
In vivo Micronucleus (Rodent): Positive
Reference: NTP
SA_36: Carbodiimides R= any alkyl group
40
C NN
RR
C
N
N
CC
CH3
CH3
CH3
CH3
Name: Diisopropylcarbodiimide
CAS: 693-13-0
In vivo Micronucleus (Rodent): Positive
Reference: NTP
N C N
Name: Dicyclohexylcarbodiimide
CAS: 538-75-0
In vivo Micronucleus (Rodent): Positive
Reference: NTP
European Commission
EUR 23844 EN – Joint Research Centre – Institute for Health and Consumer 
Protection
Title: Development of Structural alerts for the in vivo micronucleus assay in 
rodents
Author(s): Benigni R, Bossa C, Tcheremenskaia O and Worth A
Luxembourg: Office for Official Publications of the European Communities
2009 – 42 pp. – 21 x 29.7 cm
EUR – Scientific and Technical Research series – ISSN 1018-5593
Abstract
In vivo mutagenicity and carcinogenicity studies are posing a high demand for 
test-related resources. Among these studies, the micronucleus test in rodents 
is the most widely used, as follow up to positive in vitro mutagenicity results. A 
recent survey of the (Q)SAR models for mutagenicity and carcinogenicity has 
indicated that no (Q)SAR models for in vivo micronucleus are available in the 
public domain. Therefore, the development and extensive use of estimation 
techniques such as (Q)SARs, read-across and grouping of chemicals, 
promises to have a huge animal saving potential for this endpoint. In this 
report, we describe the identification of structural alerts for the in vivo
micronucleus assay, and provide the list of underlying chemical structures. 
These structural alerts provide a coarse-grain filter for the preliminary 
screening of potential in vivo mutagens.  
The mission of the JRC is to provide customer-driven scientific and technical support 
for the conception, development, implementation and monitoring of EU policies. As a 
service of the European Commission, the JRC functions as a reference centre of 
science and technology for the Union. Close to the policy-making process, it serves 
the common interest of the Member States, while being independent of special 
interests, whether private or national.
